MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202648114921 A) filed by Shionogi & Co. , Ltd.; and National University Corporation Hokkaido on September 25, 2026, for Triazine Derivative Having Virus Propagation Inhibitory Effect, And Pharmaceutical Composition Containing Same.
Inventors include Tachibana, Yuki; Uehara, Shota; Unoh, Yuto; Nakahara, Kenji; Taoda, Yoshiyuki; Yamatsu, Yukiko Filed On; Ando, Shigeru; and Sasaki, Michihito.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: ABSTRACT The present invention provides a compound exhibiting coronavirus 3CL protease inhibitory activity or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same. Furthermore, the present invention provides a crystalline form useful as an active pharmaceutical ingredient, and a pharmaceutical composition comprising the same. A compound represented by Formula: , or a pharmaceutically acceptable salt thereof.
Disclaimer: Curated by HT Syndication.
